Thomas H. Bugge

4.7k total citations
36 papers, 3.8k citations indexed

About

Thomas H. Bugge is a scholar working on Cancer Research, Hematology and Molecular Biology. According to data from OpenAlex, Thomas H. Bugge has authored 36 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cancer Research, 17 papers in Hematology and 12 papers in Molecular Biology. Recurrent topics in Thomas H. Bugge's work include Protease and Inhibitor Mechanisms (33 papers), Blood Coagulation and Thrombosis Mechanisms (17 papers) and Signaling Pathways in Disease (5 papers). Thomas H. Bugge is often cited by papers focused on Protease and Inhibitor Mechanisms (33 papers), Blood Coagulation and Thrombosis Mechanisms (17 papers) and Signaling Pathways in Disease (5 papers). Thomas H. Bugge collaborates with scholars based in United States, Denmark and Australia. Thomas H. Bugge's co-authors include Jay L. Degen, Matthew J. Flick, Daniel A. Lawrence, Maria Sandkvist, Cynthia C. Daugherty, Manuel Yepes, Elizabeth Moore, Dudley K. Strickland, Keld Danø and Stella E. Tsirka and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Thomas H. Bugge

36 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas H. Bugge United States	24	1.9k	1.3k	1.2k	575	444	36	3.8k
E. Camilla Forsberg United States	29	540 0.3×	2.8k 2.2×	1.2k 1.0×	255 0.4×	477 1.1×	74	5.8k
Deborah L. French United States	38	1.0k 0.5×	2.4k 1.9×	1.4k 1.2×	210 0.4×	568 1.3×	134	5.3k
Graham Wells United Kingdom	20	1.1k 0.6×	806 0.6×	439 0.4×	220 0.4×	364 0.8×	26	2.9k
J D Vassalli Switzerland	27	2.4k 1.3×	1.6k 1.2×	1.5k 1.2×	131 0.2×	724 1.6×	31	4.0k
Karen Carver-Moore United States	15	1.2k 0.6×	3.9k 3.0×	1.6k 1.3×	373 0.6×	394 0.9×	16	7.9k
Wendy M. Mars United States	37	725 0.4×	2.4k 1.8×	415 0.3×	971 1.7×	212 0.5×	83	6.2k
Neil V. Morgan United Kingdom	42	1.0k 0.5×	3.0k 2.3×	807 0.7×	227 0.4×	110 0.2×	109	5.7k
Ryan Reca United States	25	1.2k 0.6×	3.3k 2.5×	953 0.8×	134 0.2×	290 0.7×	43	6.0k
Meena Gujrati United States	35	1.0k 0.5×	1.5k 1.1×	226 0.2×	260 0.5×	259 0.6×	87	3.0k
Linda J. Bendall Australia	31	537 0.3×	1.6k 1.2×	1.7k 1.4×	327 0.6×	427 1.0×	79	4.9k

Countries citing papers authored by Thomas H. Bugge

Since Specialization

Citations

This map shows the geographic impact of Thomas H. Bugge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas H. Bugge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas H. Bugge more than expected).

Fields of papers citing papers by Thomas H. Bugge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas H. Bugge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas H. Bugge. The network helps show where Thomas H. Bugge may publish in the future.

Co-authorship network of co-authors of Thomas H. Bugge

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas H. Bugge. A scholar is included among the top collaborators of Thomas H. Bugge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas H. Bugge. Thomas H. Bugge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Szabo, Roman, André L. Samson, Daniel A. Lawrence, Robert L. Medcalf, & Thomas H. Bugge. (2016). Passenger mutations and aberrant gene expression in congenic tissue plasminogen activator‐deficient mouse strains. Journal of Thrombosis and Haemostasis. 14(8). 1618–1628. 12 indexed citations

Gray, Kelly, Panumart Thongyoo, Kate Owen, et al.. (2014). Potent and specific inhibition of the biological activity of the type-II transmembrane serine protease matriptase by the cyclic microprotein MCoTI-II. Thrombosis and Haemostasis. 112(8). 402–411. 30 indexed citations

Madsen, Daniel H. & Thomas H. Bugge. (2013). Imaging collagen degradation in vivo highlights a key role for M2-polarized macrophages in extracellular matrix degradation. OncoImmunology. 2(12). e27127–e27127. 18 indexed citations

Almholt, Kasper, Michael Ploug, Birgitte Rønø, et al.. (2008). Profibrinolytic Effects of Metalloproteinases during Skin Wound Healing in the Absence of Plasminogen. Journal of Investigative Dermatology. 128(8). 2092–2101. 23 indexed citations

Schwartz, Donald R., Kamiar Moin, Bin Yao, et al.. (2007). Hu/Mu ProtIn Oligonucleotide Microarray: Dual-Species Array for Profiling Protease and Protease Inhibitor Gene Expression in Tumors and Their Microenvironment. Molecular Cancer Research. 5(5). 443–454. 14 indexed citations

Zhang, Yahong, Zhao‐Hua Zhou, Thomas H. Bugge, & Larry M. Wahl. (2007). Urokinase-Type Plasminogen Activator Stimulation of Monocyte Matrix Metalloproteinase-1 Production Is Mediated by Plasmin-Dependent Signaling through Annexin A2 and Inhibited by Inactive Plasmin. The Journal of Immunology. 179(5). 3297–3304. 33 indexed citations

Филиппов, С. И., Gerald Koenig, Tae‐Hwa Chun, et al.. (2005). MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells. The Journal of Experimental Medicine. 202(5). 663–671. 106 indexed citations

Curino, Alejandro C., Vyomesh Patel, Boye Schnack Nielsen, et al.. (2004). Detection of plasminogen activators in oral cancer by laser capture microdissection combined with zymography. Oral Oncology. 40(10). 1026–1032. 20 indexed citations

Law, Benedict, Alejandro C. Curino, Thomas H. Bugge, Ralph Weissleder, & Ching‐Hsuan Tung. (2004). Design, Synthesis, and Characterization of Urokinase Plasminogen-Activator-Sensitive Near-Infrared Reporter. Chemistry & Biology. 11(1). 99–106. 69 indexed citations

10.

Law, Benedict, Jong‐Kai Hsiao, Thomas H. Bugge, Ralph Weissleder, & Ching‐Hsuan Tung. (2004). Optical zymography for specific detection of urokinase plasminogen activator activity in biological samples. Analytical Biochemistry. 338(1). 151–158. 14 indexed citations

11.

Makarova, Alexandra, Irina Mikhailenko, Thomas H. Bugge, et al.. (2003). The Low Density Lipoprotein Receptor-related Protein Modulates Protease Activity in the Brain by Mediating the Cellular Internalization of Both Neuroserpin and Neuroserpin-Tissue-type Plasminogen Activator Complexes. Journal of Biological Chemistry. 278(50). 50250–50258. 54 indexed citations

12.

Yepes, Manuel, Maria Sandkvist, Elizabeth Moore, et al.. (2003). Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor–related protein. Journal of Clinical Investigation. 112(10). 1533–1540. 437 indexed citations

13.

Netzel–Arnett, Sarah, David Mitola, Susan S. Yamada, et al.. (2002). Collagen Dissolution by Keratinocytes Requires Cell Surface Plasminogen Activation and Matrix Metalloproteinase Activity. Journal of Biological Chemistry. 277(47). 45154–45161. 69 indexed citations

14.

Frankel, Arthur E., Thomas H. Bugge, Shihui Liu, Daniel A. Vallera, & S H Leppla. (2002). Peptide Toxins Directed at the Matrix Dissolution Systems of Cancer Cells. Protein and Peptide Letters. 9(1). 1–14. 5 indexed citations

15.

Gebbia, Joseph A., et al.. (1999). The plasminogen activation system enhances brain and heart invasion in murine relapsing fever borreliosis. Journal of Clinical Investigation. 103(1). 81–87. 91 indexed citations

16.

List, Karin, Ole N. Jensen, Thomas H. Bugge, et al.. (1999). Plasminogen-Independent Initiation of the Pro-urokinase Activation Cascade in Vivo. Activation of Pro-urokinase by Glandular Kallikrein (mGK-6) in Plasminogen-Deficient Mice. Biochemistry. 39(3). 508–515. 38 indexed citations

17.

Busso, Nathalie, V Péclat, K. Van Ness, et al.. (1998). Exacerbation of antigen-induced arthritis in urokinase-deficient mice.. Journal of Clinical Investigation. 102(1). 41–50. 119 indexed citations

18.

Tsirka, Stella E., Andrew D. Rogove, Thomas H. Bugge, Jay L. Degen, & Sidney Strickland. (1997). An Extracellular Proteolytic Cascade Promotes Neuronal Degeneration in the Mouse Hippocampus. Journal of Neuroscience. 17(2). 543–552. 361 indexed citations

19.

Bugge, Thomas H., Theodore T. Suh, Matthew J. Flick, et al.. (1995). The Receptor for Urokinase-type Plasminogen Activator Is Not Essential for Mouse Development or Fertility. Journal of Biological Chemistry. 270(28). 16886–16894. 185 indexed citations

20.

Bugge, Thomas H., Matthew J. Flick, Cynthia C. Daugherty, & Jay L. Degen. (1995). Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction.. Genes & Development. 9(7). 794–807. 357 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact